157 related articles for article (PubMed ID: 36612628)
1. Impact of Clinicopathological Characteristics and Tissue Inhibitor of Metalloproteinase-3 Polymorphism Rs9619311 on Biochemical Recurrence in Taiwanese Patients with Prostate Cancer.
Hsieh CY; Lin CY; Wang SS; Chou YE; Chien MH; Wen YC; Hsieh MJ; Yang SF
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612628
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer.
Su CW; Huang YW; Chen MK; Su SC; Yang SF; Lin CW
Medicine (Baltimore); 2015 Nov; 94(46):e2092. PubMed ID: 26579821
[TBL] [Abstract][Full Text] [Related]
3. Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan.
Chung JF; Chen CL; Nassef Y; Shiu BH; Wang CH; Kuo FH; Hsiao YH; Yang SF; Wang PH
Int J Med Sci; 2022; 19(6):1013-1022. PubMed ID: 35813301
[TBL] [Abstract][Full Text] [Related]
4. Associations of
Chang JH; Lai TC; Yang PJ; Shih PC; Yang YC; Lee KL; Liu TC; Tsao TC; Yang SF; Chien MH
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126605
[TBL] [Abstract][Full Text] [Related]
5. TIMP3 Gene Polymorphisms of -1296 T > C and -915 A > G Increase the Susceptibility to Arsenic-Induced Skin Cancer: A Cohort Study and In Silico Analysis of Mutation Impacts.
Wu MM; Chen CW; Chen CY; Lee CH; Chou M; Hsu LI; Lee TC; Chen CJ
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499314
[TBL] [Abstract][Full Text] [Related]
6. Association of the interaction between the rs9619311 and rs402007 polymorphisms and smoking with essential hypertension in Chinese Han population.
Chen C; Yang M; Dou LP; Ling DM; Huang S
Medicine (Baltimore); 2020 Jun; 99(23):e20552. PubMed ID: 32502021
[TBL] [Abstract][Full Text] [Related]
7. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
8. Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer.
Hsieh CY; Chou YE; Lin CY; Wang SS; Chien MH; Tang CH; Lin JC; Wen YC; Yang SF
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33228130
[TBL] [Abstract][Full Text] [Related]
9. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
10. The impact of receptor of advanced glycation end-products polymorphisms on prostate cancer progression and clinicopathological characteristics.
Chou YE; Hsieh MJ; Wang SS; Lin CY; Chen YY; Ho YC; Yang SF
J Cell Mol Med; 2021 Nov; 25(22):10761-10769. PubMed ID: 34708514
[TBL] [Abstract][Full Text] [Related]
11. Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer.
Adissu HA; McKerlie C; Di Grappa M; Waterhouse P; Xu Q; Fang H; Khokha R; Wood GA
Prostate; 2015 Dec; 75(16):1831-43. PubMed ID: 26332574
[TBL] [Abstract][Full Text] [Related]
12. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score.
Freedland SJ; Csathy GS; Dorey F; Aronson WJ
J Urol; 2002 Feb; 167(2 Pt 1):516-20. PubMed ID: 11792909
[TBL] [Abstract][Full Text] [Related]
13. [Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease].
Korytina GF; Tselousova OS; Akhmadishina LZ; Victorova EV; Zagidullin ShZ; Victorova TV
Mol Biol (Mosk); 2012; 46(3):487-99. PubMed ID: 22888638
[TBL] [Abstract][Full Text] [Related]
14. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
[TBL] [Abstract][Full Text] [Related]
15. Impact of tissue inhibitor of metalloproteinases-3 genetic variants on clinicopathological characteristics of urothelial cell carcinoma.
Weng WC; Hsieh MH; Chiou HL; Lee CY; Tang CH; Chang LC; Wang SS; Yang SF
J Cancer; 2023; 14(3):360-366. PubMed ID: 36860920
[TBL] [Abstract][Full Text] [Related]
16. TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women.
Tsai HT; Hsieh MJ; Chiou HL; Lee HL; Hsin MC; Liou YS; Yang CC; Yang SF; Kuo WH
Tumour Biol; 2014 Sep; 35(9):8999-9007. PubMed ID: 24903383
[TBL] [Abstract][Full Text] [Related]
17. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database.
Freedland SJ; Aronson WJ; Csathy GS; Kane CJ; Amling CL; Presti JC; Dorey F; Terris MK;
Urology; 2003 Apr; 61(4):742-7. PubMed ID: 12670558
[TBL] [Abstract][Full Text] [Related]
18. Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease.
Tefik T; Kucukgergin C; Sanli O; Oktar T; Seckin S; Ozsoy C
BJU Int; 2013 Aug; 112(4):E406-14. PubMed ID: 23773345
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.
Wieczorek E; Reszka E; Jablonowski Z; Jablonska E; Krol MB; Grzegorczyk A; Gromadzinska J; Sosnowski M; Wasowicz W
BJU Int; 2013 Dec; 112(8):1207-14. PubMed ID: 23819551
[TBL] [Abstract][Full Text] [Related]
20. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.
Freedland SJ; Jalkut M; Dorey F; Sutter ME; Aronson WJ
Urology; 2000 Jul; 56(1):87-91. PubMed ID: 10869631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
